2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation

Home > Science Hub > 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation
Back to the list

December 1, 2019

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation.

Bioanalysis 2019; 11(24):2207-2244.

You might also be interested by

CellTalk Blog

ELISpot vs. ICS: Optimizing Immune Monitoring in Clinical Trials with the Right Functional Assay

November 19, 2024

Immune Monitoring

More info

CellTalk Blog

Measure Target Engagement With Receptor Occupancy Assays by Flow Cytometry

September 17, 2024

Immune Monitoring

More info

Brochures & Infographics

High Performance Technologies for Cytokine Measurement

July 29, 2024

Immune Monitoring

More info

Brochures & Infographics

Cell Therapy

December 15, 2023

Histopathology

More info